Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of FG-4592 in Healthy Young and Elderly Subjects
NCT02161796Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of roxadustat in anemia (4 arms), sponsored by Astellas Pharma. Primary endpoints: Area under the concentration-time curve from time zero to infinity and Maximum plasma concentration. Started Sep 2013; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02161796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161796.